Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2016 | Killer antibodies against AML

Mette Hazenberg • 9 Jun 2016
EHA 2016
Acute Myeloid Leukemia

Press brief by Mette Hazenberg, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.

Related Videos

1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:34
Total marrow and lymphoid irradiation plus cyclophosphamide & etoposide in poor-risk acute leukemias
Anthony Stein • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals